Insights

Innovative Therapeutics Orbit Biomedical is at the forefront of retinal gene therapy, focusing on precise surgical delivery systems that could increase demand for specialized surgical tools and training among ophthalmic surgeons and treatment centers.

Strategic Merger Strength The company's merger with Gyroscope Therapeutics positions it as a leading integrated retinal gene therapy firm, presenting opportunities to collaborate with clinics and hospitals seeking cutting-edge, comprehensive treatment solutions.

Global Presence Operating in both the US and UK, Orbit Biomedical offers a gateway to expand sales efforts across North America and Europe, targeting institutional clients involved in innovative ophthalmic care and research.

Emerging Market Potential With a focus on curative therapies for blinding conditions and a growing pipeline, there is a significant opportunity to engage with biotech and pharma companies looking to partner or license breakthrough gene delivery technologies.

Early Market Stage Given the company’s current revenue under $1 million and ongoing development, sales efforts could focus on securing early adopters, clinical trial collaborations, and securing funding or grants to accelerate product adoption and commercialization.

Orbit Biomedical, Inc. Tech Stack

Orbit Biomedical, Inc. uses 8 technology products and services including W3 Total Cache, WordPress, Mailgun, and more. Explore Orbit Biomedical, Inc.'s tech stack below.

W3 Total Cache

Caching

WordPress

Content Management System

Mailgun

jQuery

Javascript Libraries

PHP

Programming Languages

Yoast SEO

Search Engines

Bootstrap

UI Frameworks

Apache HTTP Server

Web Servers

Orbit Biomedical, Inc. Email Formats	Example	Percentage
FLast@orbitbiomedical.com	JDoe@orbitbiomedical.com	50%
FLast@orbitbiomedical.com	JDoe@orbitbiomedical.com	50%

Orbit Biomedical, Inc. Email Formats

Example

Percentage

FLast@orbitbiomedical.com

JDoe@orbitbiomedical.com

50%

FLast@orbitbiomedical.com

JDoe@orbitbiomedical.com

50%

Frequently Asked Questions

Where is Orbit Biomedical, Inc.'s headquarters located?

Orbit Biomedical, Inc.'s main headquarters is located at 300 Brookside Ave Lower Gwynedd Township, Pennsylvania US. The company has employees across 1 continents, including North America.

What is Orbit Biomedical, Inc.'s official website and social media links?

Orbit Biomedical, Inc.'s official website is orbitbiomedical.com and has social profiles on LinkedIn.

What is Orbit Biomedical, Inc.'s SIC code NAICS code?

Orbit Biomedical, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orbit Biomedical, Inc. have currently?

As of October 2025, Orbit Biomedical, Inc. has approximately 18 employees across 1 continents, including North America. Key team members include Chief Experience & Education Officer: D. B.. Explore Orbit Biomedical, Inc.'s employee directory with LeadIQ.

What industry does Orbit Biomedical, Inc. belong to?

Orbit Biomedical, Inc. operates in the Biotechnology Research industry.

What technology does Orbit Biomedical, Inc. use?

Orbit Biomedical, Inc.'s tech stack includes W3 Total CacheWordPressMailgunjQueryPHPYoast SEOBootstrapApache HTTP Server.

What is Orbit Biomedical, Inc.'s email format?

Orbit Biomedical, Inc.'s email format typically follows the pattern of FLast@orbitbiomedical.com. Find more Orbit Biomedical, Inc. email formats with LeadIQ.

When was Orbit Biomedical, Inc. founded?

Orbit Biomedical, Inc. was founded in 2018.

Orbit Biomedical, Inc.

Biotechnology ResearchPennsylvania, United States11-50 Employees

Expanding horizons in curative therapy.

Orbit Biomedical is a specialized medical device company operating at the intersection of biomedical engineering, surgeon training and curative therapeutics. Our mission is to revolutionize gene and cell therapy treatment by setting a new standard for precise, targeted surgical delivery to the sub-retinal space. 

In 2019 Orbit merged with Gyroscope Therapeutics to create a leading retinal gene therapy company. The merger creates the first fully integrated, clinical-stage, retinal gene therapy company with high quality manufacturing and a surgical platform that can support accurate, safe and consistent delivery of treatments to patients with blinding conditions. The Company operates out of Philadelphia in the US and Stevenage in the UK.

Insights

Similar companies to Orbit Biomedical, Inc.

Optos

EYEVENSYS

Aerie Pharmaceuticals

REGENXBIO

Adverum Biotechnologies

Generation Bio

Inotrem

MeiraGTx